6F4-17189-98429
3 vaccinations
10 coded responses
19 check-ins
10 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 290 / SC
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Survey response — day 0, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · HeadacheFree text: CVID primary immunodeficiency- can cause the same symptoms on a daily basis as potentially experience by the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Survey response — days 1–6 daily, dose 1MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): I tested positive for COVID-19 on January 4th · Healthcare visit (other): Because I tested positive for COVID-19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-07
Survey response — days 1–6 daily, dose 1MedDRA: COVID-19 — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I am COVID-19 positiveMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Tested positive for COVID 19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 on 01/04/2021MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — day 7, dose 1MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 on 01/04/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
-
2021-01-23
Dose 2 — Pfizer-BioNTech
-
2021-02-01
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain, Tenderness — Feeling: Fair · Headache, Fatigue or tirednessFree text: sore throat and tender neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-10
- 2021-02-13
- 2021-02-21
- 2021-02-28
-
2021-03-08
Survey response — day 42, dose 2MedDRA: COVID-19, Viral infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Possible COVID reinfection or some sort of viral infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-07-24
-
2021-08-19
Dose 3 — Pfizer-BioNTech
- 2021-09-08
- 2021-09-09
-
2021-09-16
Survey response — day 28, dose 3MedDRA: Immune thrombocytopenia, Platelet count decreased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Decrease in platelets likely due to autoimmune thrombocytopeniaMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-17
-
2021-10-04
Survey response — day 42, dose 3MedDRA: Condition aggravated, Neutropenia, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Autoimmune thrombocytopenia and neutropenia likely exacerbated by previous COVID infectionsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2021-10-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
Call center
7 call center cases
7 unsuccessful
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): CVID primary immunodeficiency- can cause the same symptoms on a daily basis as potentially experience by the vaccine
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I tested positive for COVID-19 on January 4th
Healthcare visit (other): Because I tested positive for COVID-19
Systemic reaction (other): I am COVID-19 positive
Systemic reaction (other): Tested positive for COVID 19
Systemic reaction (other): Tested positive for COVID-19 on 01/04/2021
Release 1 — day 7, dose 1
Systemic reaction (other): Tested positive for COVID-19 on 01/04/21
Release 3 — day 7, dose 2
Systemic reaction (other): sore throat and tender neck
Release 5 — day 42, dose 2
Symptoms: Possible COVID reinfection or some sort of viral infection
Release 9 — day 28, dose 3
Symptoms: Decrease in platelets likely due to autoimmune thrombocytopenia
Release 10 — day 42, dose 3
Symptoms: Autoimmune thrombocytopenia and neutropenia likely exacerbated by previous COVID infections
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | ○ | ✓ | ○ |
| SD | Immune thrombocytopenia | · | · | ✓ |
| SD | Neutropenia | · | · | ✓ |
| SD | Platelet count decreased | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Viral infection | ✓ | ✓ | ✓ |
| SRO | COVID-19 | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release